Table 1– Patient demographic, anthropometric and baseline data

Demographics
Age yrs	47±13
Males/females n	26/1
BMI kg·m⁻²	31.3±3.8
Medical history and medication n
Hypertension	9
Type 2 diabetes	2
Hypercholesterolaemia	10
Antihypertensive agents	9
Oral hypoglycaemic agents	1
Insulin	0
Statins	7
Sleep apnoea
AHI events·h⁻¹	37.2±24.7
ODI events·h⁻¹	30.3±22.6
TST with S_a,O₂ <90% %	7.1±11.7
Minimum S_a,O₂ %	78.0±11.4
ESS score	10.0±4.8
LFT
ALP^# U·L⁻¹	72.5±13.9
AST^¶ U·L⁻¹	26.6±8.1
ALT^¶ U·L⁻¹	41.1±19.9
GGT⁺ U·L⁻¹	33.9±17.5
Total protein^§ g·L⁻¹	74.0±4.2
Albumin^ƒ g·L⁻¹	45.3±2.3
Bilirubin^## μmol·L⁻¹	12.9±6.5
Fasting glucose^¶¶ mmol·L⁻¹	5.7±1.6
Adipose tissue
Subcutaneous fat cm³	2784.9±946.9
Visceral fat cm³	1179.7±530.9
IHL %	5.2±2.1

Data are presented as mean±sd,unless otherwise stated.BMI: body mass index; AHI: apnoea–hypopnoea index; ODI: oxygen desaturation index; TST: total sleep time; S_a,O₂: arterial oxygen saturation; ESS: Epworth Sleepiness Scale; LFT: liver function test; ALP: alkaline phosphatase; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: γ-glutamyltransferase; IHL: intrahepatic liquid. ^#: normal reference range 30–130 U·L⁻¹; ^¶: normal reference range 5–55 U·L⁻¹; ⁺: normal reference range <35 U·L⁻¹; ^§: normal reference range 62–80 g·L⁻¹; ^ƒ: normal reference range 38–48 g·L⁻¹; ^##: normal reference range <18 μmol·L⁻¹; ^¶¶: normal reference range 3.9–5.5 mmol·L⁻¹.